ISO/IEC 17025 is a standard for testing and calibration laboratories. It does not certify a peptide. It does not certify a supplier. It applies to the laboratory that produced a result, and only for the tests listed on that laboratory's scope of accreditation. For a researcher buying peptides in Australia, the useful question is not "is this ISO 17025 peptide stock?" but "was the purity and identity data on this Certificate of Analysis (COA) produced by a lab accredited for that exact method?"
This guide explains what the standard covers, how to verify a claim in a few minutes, what a COA should contain, and where Australian regulation sits alongside all of it.
TL;DR
- ISO/IEC 17025 accredits laboratories, not peptides and not sellers. Accreditation is granted per test, listed on a scope.
- "ISO 17025 compliant" or "ISO-aligned" is not the same as accredited. Ask for the scope and check it with the accreditation body, such as NATA in Australia.
- A COA should show method (RP-HPLC, mass spectrometry), batch ID, sequence identity and purity. One study found only 44% of synthetic peptides met supplier purity claims.
- A "research use only" label does not change TGA status. The TGA treats peptides promoted for therapeutic outcomes as therapeutic goods.
- Peptastic Labs supplies HPLC-verified, mass-spec-tested batches at ≥99% purity with COAs on request. Ask for the testing lab's scope before relying on any accreditation statement.
Table of Contents
- What ISO/IEC 17025 is
- Accredited, compliant, aligned: three different claims
- How to verify a lab's scope in five steps
- What a peptide COA should show
- Where ISO 17025 fits and where it does not
- Australian regulation: the TGA position
- Our perspective on accreditation
- Ordering with documentation in mind
- FAQ
- Sources
What ISO/IEC 17025 is
ISO/IEC 17025 sets technical and management system requirements for testing and calibration laboratories. In Australia, NATA accredits laboratories to ISO/IEC 17025, and describes the standard as the benchmark for deeming a lab technically competent for the methods and procedures on its scope of accreditation.
Three features matter for peptide buyers:
- Competence of a laboratory. Staff, equipment, method validation, traceability of measurements and record keeping are assessed by an independent accreditation body.
- Scope-specific. Accreditation is granted against defined tests. A lab accredited for food microbiology is not thereby accredited for peptide purity by HPLC.
- Results, not products. Accreditation supports confidence in the data. It says nothing about whether a compound is lawful, safe or fit for a particular study.
The International Laboratory Accreditation Cooperation (ILAC) guidance on securing testing services makes the same point: a lab can offer its own assurances, but confidence comes from accreditation by a body that evaluated the lab against the standard, and the tests you need must fall within the accredited scope.
Accredited, compliant, aligned: three different claims
Peptide supplier pages use the standard's name in several ways. They are not equivalent.
| Wording on a page | What it usually means | What to ask for |
|---|---|---|
| "Tested by an ISO/IEC 17025 accredited laboratory" | A named lab holds accreditation. Scope still unverified. | Lab name, accreditation number, current scope |
| "ISO 17025 compliant" or "follows ISO 17025" | Self-declared. No external assessment implied. | Evidence of independent assessment |
| "ISO-certified facility" | Often a different standard (for example ISO 9001) for a management system | Which standard, which body, which site |
| "Third-party tested" | Testing done outside the supplier. Says nothing about accreditation. | Lab identity, method, report |
The ILAC factsheet on specifying accreditation in regulation separates two conditions: the provider must be accredited to the relevant standard, and the specific tests requested must be listed on the scope. Both conditions apply to a peptide COA.
How to verify a lab's scope in five steps
This takes minutes and works for any supplier, including us.
- Get the lab's name and accreditation number from the COA or the supplier. A COA with no lab identity cannot be checked.
- Check the accreditation body. NATA is the Australian body. Overseas labs are accredited by bodies that are signatories to the ILAC MRA, which have been peer evaluated against ISO/IEC 17011.
- Request the schedule or scope of accreditation from the lab or the accreditation body's directory.
- Match the method. Look for chromatographic purity by HPLC, or LC-MS identity testing, or an equivalent technique covering peptides. A scope listing only unrelated tests does not cover your COA.
- Check the report. An accredited result normally carries the lab's identity and accreditation reference, a sample identifier and the method used. Compare the batch number on the report with the batch number on your vial.
If any step fails, treat the accreditation statement as unverified. That is a reasonable position, not an accusation.
What a peptide COA should show
Accreditation is one layer. The content of the report matters just as much. A usable COA lists:
- Compound name and sequence or molecular formula
- Batch or lot number matching the vial label
- Test date and testing laboratory
- Method: RP-HPLC conditions (column, gradient, detection wavelength)
- Chromatogram, not only a percentage
- Mass spectrometry result with observed versus theoretical mass
- Purity value, stated as the method defines it (for example, area percent at a stated wavelength)
- Net peptide content or water and counter-ion content where measured
Analytical workflows for peptides typically use reverse-phase HPLC for separation and electrospray ionization mass spectrometry for structural confirmation, because synthetic peptides contain closely related impurities, such as sequences missing an amino acid, that a simple purity number can hide.
Why a single percentage is not enough
A main peak at 99% by UV area does not tell you what sits under or beside it. Co-eluting impurities, deletion sequences and modified forms can share retention behavior with the target. Mass spectrometry confirms identity, and HPLC reports relative purity. Neither alone answers every question. For deeper reading, see our notes on peak purity checks, UV limits and MS, on impurity profiling methods and on when HPLC or LC-MS is the better QC choice.
A COA is a claim until it is checked
In a study evaluating synthetic peptides bought for R&D, only 44% met the purity stated by the supplier when independently verified. The peptides in that study were quorum sensing peptides, not the compounds in every catalog, and the finding does not describe any single supplier. It does show why accreditation status, batch traceability and independent re-testing belong together.
Practical consequences for a lab:
- Keep the COA with the batch number in your records.
- Re-test critical batches in-house or through a lab with the right scope when the study depends on exact purity.
- Record storage, reconstitution and handling, since degradation after receipt changes what you actually dose in an assay.
- Inspect vials on arrival. Our guide on vial contamination causes and warning signs lists what to look for.
Where ISO 17025 fits and where it does not
| Question | Does ISO/IEC 17025 answer it? |
|---|---|
| Is the HPLC result from a competent lab? | Yes, when the method is on the scope |
| Is the supplier's sampling representative of the batch? | Only if sampling is within the scope |
| Is the peptide lawful to import or supply in Australia? | No |
| Is the product safe for human use? | No |
| Is a reconstituted vial still within spec after weeks? | No |
| Is the compound the correct sequence? | Only if identity testing (MS) is in scope and performed |
The standard improves the reliability of a measurement. It is silent on legality and on human safety.
Australian regulation: the TGA position
This is the part most "ISO 17025 peptides" pages skip.
The Therapeutic Goods Administration regulates therapeutic goods under the Therapeutic Goods Act 1989. Its page on how it regulates therapeutic peptide products explains that peptide products promoted for therapeutic outcomes, such as weight loss, muscle growth or cognitive enhancement, are considered therapeutic goods. They generally need to be included on the Australian Register of Therapeutic Goods (ARTG) unless an exemption, authority or approval applies.
The TGA's safety alert on importing, compounding and supplying unapproved peptide products, dated 2026-04-09, states concern about rising import, supply and advertising of unapproved peptides. The agency's position, as summarized in its guidance, is that labels such as "research use only" or "not for human use" do not alter the regulatory status of a product intended to modify physiological processes.
What this means in practice:
- Laboratory research. Peptides purchased for in vitro, analytical or other laboratory work by qualified researchers are a different situation from products promoted to consumers. Check your institution's compliance office and the import requirements that apply to your project. Our guide to the documents Australian labs attach to import research peptides and the note on HS codes and customs delays cover the paperwork side.
- Human use. No accreditation of a testing lab, and no COA, makes an unapproved peptide approved. The TGA's peptide products page notes that these products are promoted online for weight loss, muscle growth, anti-ageing, recovery and performance, and that while some are approved, many are not. If you are considering a peptide for yourself, speak to a doctor. Access to unapproved therapeutic goods is through prescriber pathways described by the TGA, not through a research catalog. Our summary of peptide prescription requirements in Australia explains the routes.
- Responsibility. For unapproved goods, the TGA does not provide quality assurance on the product. Chemical identity and purity checks fall on whoever handles the material. That is the practical reason verified testing matters.
The TGA reports that adverse events associated with unapproved peptide products have included systemic inflammatory response syndrome, severe allergic reactions and musculoskeletal injuries, as set out on its regulation page. Anyone who has used such a product and become unwell should seek medical care and tell the treating clinician exactly what was taken.
Our perspective on accreditation
We treat accreditation as one control among several, not as a label.
What we state about our own quality system: each peptide batch is independently tested by HPLC and mass spectrometry, the catalog is verified to ≥99% purity by HPLC, batch documentation is traceable, and a Certificate of Analysis is available on request. We do not claim on this page that any specific testing laboratory holds ISO/IEC 17025 accreditation, and we suggest buyers do not accept that claim from any supplier without the lab name and scope in hand. If you want the scope of the laboratory behind a given batch, ask when you request the COA, and compare it against the method on the report.
Our view on what a researcher should demand from any source:
- A COA that names the lab and the batch
- Chromatograms and mass data, not a summary line
- Willingness to answer scope questions without deflecting
- Clear statements about intended use and Australian import obligations
- Independent re-testing for studies where purity drives the conclusion
A percentage on a web page is a starting point. Documentation that can be audited is the standard worth asking for.
— Tintastic
Ordering with documentation in mind
The Peptastic Labs catalogue covers Metabolic, Cognitive & Neuro, Tissue & Repair, Longevity, Cosmetic Science, Blends, Hormone & Reproductive, and Ancillaries & Reagents lines. Items are supplied for laboratory research, with batch documentation and COAs on request, and bulk or wholesale options are available. Prices are not published on the catalogue page, so confirm them at order. For typical market pricing context, see our peptide cost overview for Australia. For examples of lawful laboratory use, see Australian peptide research use.
Before ordering, have ready:
- Your institution or organization name and research purpose
- The compound and batch you need documentation for
- Any scope or method questions about the COA
FAQ
Can a peptide be "ISO 17025 certified"?
No. The standard applies to laboratories, which are accredited, not to products. A supplier may use an accredited lab to test a batch, and the report should name that lab and method. Treat "ISO 17025 certified peptide" as an imprecise phrase and ask what exactly was assessed.
How do I check that a lab is accredited for peptide purity?
Get the lab's name and accreditation number, then look up its scope of accreditation with the accrediting body, such as NATA for Australian labs. Confirm that a method such as HPLC purity or LC-MS identity for peptides appears in the scope. A general statement of compliance is not enough, as ILAC guidance on scope makes clear.
Does an accredited COA make a peptide legal to use in Australia?
No. Accreditation concerns the reliability of test data. Legal status is a matter for the TGA and the Therapeutic Goods Act 1989, and a research-use label does not remove a product from that framework if it is promoted for therapeutic effects. Check import and institutional requirements before ordering.
Is a COA enough to trust a batch?
It is necessary but not always sufficient. A published study found that only 44% of the synthetic peptides it examined met supplier purity claims on independent testing. For critical work, re-test the batch yourself or through a laboratory whose scope covers the method.
Sources
- NATA: Testing & Calibration (ISO/IEC 17025) Accreditation
- ILAC: Securing testing, measurement or calibration services
- ILAC: Factsheet on specifying accreditation in regulation
- ILAC: Accredited conformity assessment bodies
- PubMed: Quality evaluation of synthetic quorum sensing peptides used in R&D
- TGA: How we regulate therapeutic peptide products
- TGA: Understanding your responsibilities when importing, compounding and supplying unapproved peptide products
- TGA: Peptide products
- TGA: Peptide product information for health practitioners